![Stefan Persson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Stefan Persson
Entité | Type d'entité | Industrie | |
---|---|---|---|
Pharmacia Corp.
![]() Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
71
| Extinct | Pharmaceuticals: Major | 71 |
University of Uppsala
45
| College/University | Other Consumer Services | 45 |
Resistentia Pharmaceuticals AB
![]() Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Resistentia Pharmaceutical's business strategy is to develop and commercialize immunotherapy as a second generation therapy to monoclonal antibodies for the treatment of chronic diseases. Resistentia’s most advanced program is an immunotherapy against allergy/asthma – a growing health problem with a large unmet medical need. In contrast to existing therapies, which are largely symptomatic, Resistentia’s novel immunotherapeutic approach targets the cause of the allergic reactions, rather than the symptoms. In addition, Resistentia is developing an immunotherapy for the treatment of rheumatoid arthritis. The project is currently in discovery phase.
16
| Extinct | Pharmaceuticals: Major | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stefan Persson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Compliance Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ERICSSON | Telecommunications Equipment | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
MONSANTO | Wholesale Distributors | Director of Finance/CFO Corporate Officer/Principal Public Communications Contact General Counsel Corporate Officer/Principal Human Resources Officer | |
ST-Ericsson SA
![]() ST-Ericsson SA Specialty TelecommunicationsCommunications ST-Ericsson designs, develops and creates mobile platforms and wireless semiconductors. The firm supplies products and technologies to handset manufacturers. The company was founded on February 2, 2009 and is headquartered in Plan-les-Ouates, Switzerland. | Specialty Telecommunications | Chairman Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman President Director of Finance/CFO | |
Svenskt Näringsliv
![]() Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet | College/University | Director/Board Member Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
OREXO AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Temple University (Pennsylvania) | College/University | Masters Business Admin Undergraduate Degree | |
St. Joseph's University | College/University | Undergraduate Degree Undergraduate Degree | |
Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
Newron Sweden AB
![]() Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chairman Chairman Chief Tech/Sci/R&D Officer | |
Arexis AB
![]() Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
University of Stockholm | College/University | Doctorate Degree Graduate Degree Director/Board Member Masters Business Admin Undergraduate Degree | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Corporate Officer/Principal Doctorate Degree | |
Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Henley Management College | College/University | Masters Business Admin Masters Business Admin | |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
![]() Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Healthcap 1999 GP AB
![]() Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Ericsson Danmark A/S
![]() Ericsson Danmark A/S Specialty TelecommunicationsCommunications Ericsson Danmark A/S provides information and communication technology solutions. It specializes in industrial automation, 4G networks, cellular internet of thing, routers, optical transport networks, and network intelligence and automation. The firm serves information, communications, and technology sectors. The company was founded on January 9, 1929 and is headquartered in Copenhagen, Denmark. | Specialty Telecommunications | Chief Executive Officer Director of Finance/CFO | |
Ericsson AB
![]() Ericsson AB Information Technology ServicesTechnology Services Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden. | Information Technology Services | Director/Board Member Chief Executive Officer | |
KANCERA AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
Tessa Therapeutics Ltd
![]() Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chairman | |
QuiaPEG Pharmaceuticals AB
![]() QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
NANEXA AB | Medical Specialties | Chairman Chairman Chief Tech/Sci/R&D Officer | |
QUIAPEG PHARMACEUTICALS HOLDING AB | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Ernst & Young Management Consultancy Services
![]() Ernst & Young Management Consultancy Services Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young Management Consultancy Services provides management consulting services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal |
Statistiques
Internationale
Suède | 29 |
Etats-Unis | 15 |
Danemark | 4 |
Suisse | 3 |
Canada | 2 |
Sectorielle
Health Technology | 28 |
Consumer Services | 10 |
Commercial Services | 6 |
Electronic Technology | 3 |
Communications | 3 |
Opérationnelle
Director/Board Member | 571 |
Corporate Officer/Principal | 225 |
Chairman | 167 |
Independent Dir/Board Member | 125 |
Chief Executive Officer | 97 |
Relations les plus connectées
Insiders | |
---|---|
Erik Kjellsson Nerpin | 79 |
Gustav Ingemar Kihlström | 51 |
Carola Elisabet Lemne | 47 |
Göran Albert Ando | 44 |
Jan Magnus Frykhammar | 38 |
Johan Rutger Christenson | 35 |
Åsa Wirén | 35 |
Mark Corrigan | 29 |
Deborah Harland | 27 |
Paul Edick | 27 |
Håkan Åström | 26 |
Staffan Lindstrand | 25 |
Charles Rowland | 25 |
Francesco Granata | 24 |
Timothy Rothwell | 24 |
- Bourse
- Insiders
- Stefan Persson
- Connexions Sociétés